Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 4 months 26 days ago

RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation

Shareholders General Meeting Resolutions Approval Biophytis SA
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 4 months 26 days ago

RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024
Biophytis annonce l'approbation des résolutions lors de l'Assemblée Générale Mixte du 24 Juin 2024. Détails des décisions et perspectives de la société

Biophytis Biotechnologie Assemblée Générale Mixte Approbation Des Résolutions Développement De Traitements
BRIEF

published on 06/20/2024 at 07:05, 5 months 1 day ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine

Biophytis Partenariat Amérique Latine BIO101 Blanver
BRIEF

published on 06/20/2024 at 07:05, 5 months 1 day ago

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million

Biophytis Pharmaceuticals Latin America BIO101 Blanver
PRESS RELEASE

published on 06/20/2024 at 07:00, 5 months 1 day ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires

Biophytis Accord BIO101 Blanver Am\u00e9rique Latine
PRESS RELEASE

published on 06/20/2024 at 07:00, 5 months 1 day ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development

Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 5 months 1 day ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€

Biophytis Amérique Latine Accord De Licence BIO101 Blanver
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 5 months 1 day ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced

Biophytis Latin America BIO101 Exclusive Rights Blanver
BRIEF

published on 06/20/2024 at 01:15, 5 months 2 days ago

Biophytis extends its contract with Atlas to finance its clinical activities

Biophytis Biotechnology Convertible Bonds Funding Atlas
BRIEF

published on 06/20/2024 at 01:15, 5 months 2 days ago

Biophytis prolonge son contrat avec Atlas pour financer ses activités cliniques

Biophytis Biotechnologie Financement Obligations Convertibles Atlas

Accesswire

Published on 11/22/2024 at 00:00, 6 hours 26 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 8 hours 21 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 36 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 10 hours 11 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 10 hours 16 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 11 hours 25 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 50 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 12 hours 28 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 12 hours 35 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours 35 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 23 hours 28 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 23 hours 28 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 23 hours 28 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 10 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 11 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE